1. Home
  2. GSIW vs ADXN Comparison

GSIW vs ADXN Comparison

Compare GSIW & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • ADXN
  • Stock Information
  • Founded
  • GSIW 2016
  • ADXN 2002
  • Country
  • GSIW Hong Kong
  • ADXN Switzerland
  • Employees
  • GSIW N/A
  • ADXN N/A
  • Industry
  • GSIW
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIW
  • ADXN Health Care
  • Exchange
  • GSIW Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • GSIW 12.3M
  • ADXN 8.0M
  • IPO Year
  • GSIW 2023
  • ADXN N/A
  • Fundamental
  • Price
  • GSIW $0.51
  • ADXN $7.49
  • Analyst Decision
  • GSIW
  • ADXN Strong Buy
  • Analyst Count
  • GSIW 0
  • ADXN 1
  • Target Price
  • GSIW N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • GSIW 11.8M
  • ADXN 17.9K
  • Earning Date
  • GSIW 12-31-2024
  • ADXN 03-24-2025
  • Dividend Yield
  • GSIW N/A
  • ADXN N/A
  • EPS Growth
  • GSIW N/A
  • ADXN N/A
  • EPS
  • GSIW N/A
  • ADXN 0.06
  • Revenue
  • GSIW $1,313,795.00
  • ADXN $701,260.00
  • Revenue This Year
  • GSIW N/A
  • ADXN N/A
  • Revenue Next Year
  • GSIW N/A
  • ADXN N/A
  • P/E Ratio
  • GSIW N/A
  • ADXN $0.92
  • Revenue Growth
  • GSIW N/A
  • ADXN N/A
  • 52 Week Low
  • GSIW $0.43
  • ADXN $6.73
  • 52 Week High
  • GSIW $15.00
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 44.50
  • ADXN 42.98
  • Support Level
  • GSIW $0.46
  • ADXN $6.73
  • Resistance Level
  • GSIW $0.57
  • ADXN $7.90
  • Average True Range (ATR)
  • GSIW 0.11
  • ADXN 0.41
  • MACD
  • GSIW -0.00
  • ADXN -0.07
  • Stochastic Oscillator
  • GSIW 5.64
  • ADXN 18.29

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: